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Uric acid (UA) is the end product of endogenous and dietary purine nucleotide metabolism in humans. The liver enzyme xanthine oxidase oxidizes hypoxanthine to xanthine, and can further catalyze the oxidation of xanthine to UA. The kidney excretes 70% of the UA, whereas the remaining 30% has a biliary/gastrointestinal tract excretion. It is accordingly con ceived that serum level of urate is the sum of its production and excretion.
A growing body of data suggests a putative pathogenetic role for hyperuricemia in atherosclerosis and cardiovascular dis ease (CVD), especially in patients with diabetes mellitus, heart failure, and hypertension. 1 Importantly, prospective studies have demonstrated independent and significant associations of increased UA levels and cardiovascular events. 2, 3 As regards blood pressure, elevated levels of UA have been identified as an independent predictor of hypertension incidence and pro gression. 4 Importantly, treatment with allopurinol has shown to be effective in reducing blood pressure in newly diagnosed hypertensive adolescents. 5, 6 Compelling evidence suggests that UA is not an inert molecule; it induces a proinflammatory state, 7, 8 activates the renin-angiotensin-aldosterone system directly at the vascular level and indirectly by inducing tubulo interstitial disease and consequent impaired baroreflex func tion, stimulates vascular smooth muscle cell proliferation and reactive oxygen species production, 9 promotes endothelial dysfunction, 10 and arterial stiffening. [11] [12] [13] Large artery stiffness and arterial wave reflections are impor tant determinants of left ventricular function, coronary blood flow, and mechanical integrity of the arteries. Importantly, they have been identified as independent markers of CVD and predictors of risk. [14] [15] [16] [17] Furthermore, they hold a pivotal role in the hypertensive continuum. Altered elastic properties of the Background Serum uric acid (Ua) plays a key role in the development and progression of hypertension. We investigated the association of Ua levels and indices of arterial function in a cohort of newly diagnosed, never-treated hypertensive subjects.
Methods
One thousand two hundred and twenty-five patients with a new diagnosis of mild to moderate arterial hypertension for which they had never received treatment were enrolled in the study (mean age 52.9 years, 728 men). Serum Ua, carotid-femoral pulse-wave velocity (cfPWV), an index of aortic stiffness and augmentation index (aIx), a composite marker of wave reflections and arterial stiffness were measured.
results
In univariable analysis, Ua levels correlated with cfPWV (r = 0.23, P < 0.001) and aIx (r = −0.24, P < 0.001). In multiple linear regression analysis, an independent positive association of cfPWV with Ua levels was observed after adjusting for confounders (standardized regression coefficient β = 0.169, P < 0.001, adjusted R 2 = 0.402), indicating an increase in aortic stiffness with higher values of Ua. In contrast, an independent negative association of aIx with Ua levels was observed after adjusting for confounders (standardized regression coefficient β = −0.064, P = 0.011, adjusted R 2 = 0.557), indicating a decrease in wave reflections with higher values of Ua. In gender-specific analyses, Ua positively correlated with cfPWV in both genders, whereas a negative correlation with aIx existed only in females.
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Uric Acid and Arterial Function in Hypertension arteries may be both a cause and consequence of hypertension, as part of a complex pathophysiological interplay. 18 The relationship between UA, arterial stiffness, and wave reflections in hypertensive subjects has not been defined. In the present study, we sought to evaluate such relationships in a newly diagnosed hypertensive population, naive to antihyper tensive medications by measuring carotidfemoral pulsewave velocity (cfPWV), central pressures, and augmentation index (AIx).
Methods
We enrolled 1,225 patients followed at the 1st Department of Cardiology of Athens Medical School with a new diagno sis of arterial hypertension for which they had never received treatment. They underwent a standardized medical history and examination, anthropometric measurements, laboratory tests, and a 12lead electrocardiogram. The glycemic status of the participants was determined according to guidelines, with the use of an oral glucose tolerance test where appropriate. 19 Participants with coronary artery disease, cerebrovascular dis ease, peripheral artery disease, systemic inflammatory disease, and gout were excluded. Use of antiinflammatory agents, including aspirin and corticosteroids, anticoagulants, anti diabetics, lipid and UAlowering drugs were also exclusion criteria.
Participants refrained from smoking, exercise, and caffein ated beverages for at least 3 h before visits. Blood samples were obtained after a 12h fast; full blood count, creatinine, lipo protein profile, blood glucose, Creactive protein (CRP), and UA levels were determined. Weight and height were measured and body mass index was calculated. Estimated glomeru lar filtration rate was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation. 20 Regarding glucose metabolism, patients were classified as dia betics, having impaired glucose tolerance, impaired fasting glucose, or euglycemic. Participants gave informed consent to participate in the study, which was approved by the local ethics committee.
Diagnosis of arterial hypertension. Blood pressure levels were obtained in the left arm after resting for 10 min using a mercury sphygmomanometer. Measurements were obtained between 0900 and 1100 h in the sitting and standing position. A mini mum of three readings was taken spaced by 1 min. The first and fifth phase of the Korotkoff sounds were used to identify systolic blood pressure and diastolic blood pressure, respec tively. Measurements were repeated after 2 weeks in the same settings. Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg on two different occasions. Pulse pressure was calculated as systo lic blood pressure − diastolic blood pressure.
Arterial stiffness evaluation. The pulse travels at a higher velocity in a stiff aorta and vice versa. cfPWV, an established index of aortic stiffness, 14 was calculated from measurements of pulse transit time and the distance travelled between two recording sites (PWV = distance (m)/transit time (s)) using a validated noninvasive device (Complior; Artech Medical, Pantin, France), as previously described. 14, 21 Two differ ent pulse waves were obtained simultaneously (at the base of the neck for the common carotid and over the right femoral artery) with transducers. Distance was defined as: (distance from suprasternic notch to femoral artery) -(distance from carotid artery to suprasternic notch).
Measurement of aortic pressures and wave reflection indices.
AIx of the central (aortic) pressure waveform is a composite measure of the magnitude of wave reflections and arterial stiff ness, which affects timing of wave reflections. 14, 22 AIx was measured by using a validated system (SphygmoCor; AtCor Medical, Sydney, Australia) that employs the principle of applanation tonometry and appropriate software for noninva sive recording and analysis of the arterial pulse, as previously described. 14, 22 Peripheral pulse waves were recorded from the radial artery using applanation tonometry. Radial pulse waves were transformed into the aortic pulse wave through pulse wave analysis, and aortic pressures were calculated. Mean arterial pressure was calculated as the integral of the aortic pressure waveform. Larger values of AIx indicate increased wave reflections from the periphery and/or earlier return of the reflected wave as a result of increased PWV (due to increased arterial stiffness), and vice versa. AIx was averaged from 10 to 12 successive waves and was corrected for a steady heart rate of 75 beats/min. 23 General cardiovascular risk profile estimation. The general cardio vascular risk profile algorithm by the Framingham Heart Study group 24 was used to calculate the 10year risk of CVD (i.e., coronary death, myocardial infarction, coronary insufficiency, angina, ischemic stroke, hemorrhagic stroke, transient ischemic attack, peripheral artery disease, heart failure). Because the aforementioned algorithm was deducted in a population between 30 and 74 years of age, we limited our analysis to the same age group (n = 1,143).
Statistical analysis. Statistical normality was checked using the Kolmogorov-Smirnov test. Normally distributed continuous variables are presented as mean ± s.d. Nonnormally distri buted variables are presented as median (25-75th percentile) and were logtransformed for analyses. Categorical variables are reported as frequencies and percentages. Correlations among study variables were examined by Pearson's correlation coefficient. Preliminary analyses were performed to ensure no violation of the assumptions of normality, linearity, and homoscedasticity.
The abovementioned unadjusted associations of UA levels with cfPWV and AIx may have been confounded by demo graphic variables and clinical characteristics, which are impor tant determinants of arterial properties. Therefore, we applied standard multiple linear regression analyses with cfPWV (model 1) or AIx (model 2) as dependent variables and UA as an independent variable. Determinants of arterial elastic original contributions
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properties were also introduced as covariates. In particular, smoking status, sex, diabetes mellitus (dichotomous variables) and age, height, weight, total cholesterol, estimated glomeru lar filtration rate, mean arterial pressure, and CRP were used as covariates. Heart rate was introduced as a covariate in the cfPWV model but not in the AIx model, as AIx was adjusted for heart rate. Correlations and multiple linear regression anal yses were also performed for each gender separately.
The effect of UA on cfPWV and AIx was further examined by multivariate analysis of covariance (MANCOVA). In order to test whether the association of UA with arterial elastic proper ties was different across genders, MANCOVA was performed for the entire population, with the inclusion of a gender × UA interaction. Two MANCOVAs (one for each gender) were also performed, with cfPWV and AIx as dependent variables. The independent variables were smoking status and presence of diabetes mellitus; covariates were age, height, weight, total cholesterol, estimated glomerular filtration rate, mean arterial pressure, heart rate, and CRP. Preliminary assumption test ing was conducted to check for normality, linearity, univariate and multivariate outliers, homogeneity of variance-covariance matrices, and multicollinearity, with no serious violations noted.
Statistical analyses were performed with SPSS 13.0 (SPSS, Chicago, IL). A twotailed P value <0.05 was considered significant.
results
Subject characteristics, mean values of peripheral/central pres sures, and arterial function indices are presented in Tables 1  and 2 . Median values for cfPWV and AIx were 7.9 m/sec and 27% respectively, while median UA levels were 5.25 mg/dl.
entire population analysis
Univariable analysis yielded significant associations of UA levels, arterial function indices, and clinical characteristics of the study population (see Supplementary Data online).
In model 1, a significant positive association of cfPWV with UA levels was observed after adjusting for confounders (stand ardized regression coefficient β = 0.169, P < 0.001, adjusted R 2 = 0.402), indicating an increase in aortic stiffness with higher values of UA ( Table 3) .
In model 2, a significant negative association of AIx with UA levels was observed after adjusting for confounders (standard ized regression coefficient β = −0.064, P = 0.011, adjusted R 2 = 0.557), indicating a decrease in wave reflections with higher values of UA ( Table 3) .
MANCOVA in the entire population with cfPWV and AIx as dependent variables yielded similar results with the 
gender-specific analysis
The associations of UA with cfPWV and AIx were also analyzed in each gender separately (univariable analysis: Supplementary Data online; multiple linear regression models: Table 3 ). UA positively correlated with cfPWV both in men (r = 0.20, P < 0.001; standardized regression coefficient β = 0.120, P < 0.001, adjusted R 2 = 0.433), and women (r = 0.34, P < 0.001; standardized regression coefficient β = 0.184, P < 0.001, adjusted R 2 = 0.350).
Regarding wave reflections, UA did not correlate with AIx in men (r = 0.04, P = 0.267). In women a negative, yet weak, correlation was noted (r = −0.10, P = 0.028; standardized regression coefficient β = −0.127, P = 0.005, adjusted R 2 = 0.288).
When a MANCOVA model with a gender × UA interac tion was applied to the entire population (males and females) multivariate tests revealed an interaction effect of gender × UA with the combined dependent variables: When the two genders were examined separately, the results were similar. In MANCOVAs, there was a signifi cant relation of UA with the combined dependent variables (cfPWV, AIx) in both genders: F 2,483 = 14.08, P < 0.001; Pillai's trace = 0.055; η 2 = 0.055 for females; F 2,714 = 7.65, P = 0.001; Pillai's trace = 0.021; η 2 = 0.021 for males. When dependent variables were considered separately, the differ ences that reached statistical significance after Bonferroni correction for multiple comparisons were both cfPWV (F 1,484 = 18.45, P < 0.001, η 2 = 0.037; UA correlation coef ficient B = 0.108, 95% CI: 0.059, 0.158, P < 0.001) and AIx for females (F 1,484 = 8.12, P = 0.005, η 2 = 0.017; UA correlation coefficient B = −7.622, 95% CI: −12.877, −2.367, P = 0.005). In males, this was only the case for cfPWV (F 1,715 = 15.05, P < 0.001, η 2 = 0.021; UA correlation coefficient B = 0.101, 95% CI: 0.050, 0.152, P < 0.001), but not for AIx (F 1,715 = 0.007, P = 0.932; UA correlation coefficient B = −0.249, 95% CI: −6.015, 5.517, P = 0.932).
association of ua levels and 10-year general cardiovascular risk
In our study population, serum UA levels correlated with 10year general CVD risk (r = 0.31, P < 0.001) (see Supplementary Data online).
discussion
To the best of our knowledge, this is the first study to explore relationships between UA, arterial stiffness, and wave reflec tions in a newly diagnosed, nevertreated, hypertensive population. Our findings demonstrate a positive correla tion between serum UA levels and arterial stiffness, i.e., as serum UA levels increase, cfPWV increases in both genders. Interestingly enough, the correlation of UA with wave reflec tions is of a negative, yet weak nature; however, this is the case only in females, where increased UA levels are linked to lower AIx values. In addition, serum UA was shown to correlate with 10year general CVD risk.
Regarding the relationship between UA and large artery stiffness, our findings are in line and extend observations that are limited to healthy subjects and general population. In Japanese individuals, UA was associated with an increase in arterial stiffness, as estimated by brachialankle PWV. 11, 12 In young, healthy individuals, a correlation between UA levels and echocardiographic indices of arterial stiffness was reported. 25 The effect of UA levels on arterial stiffness in our population was independent of factors that influence cfPWV, such as blood pressure, smoking, lipids, glucose metabolism, anthropometric characteristics, kidney function and CRP, sug gesting a direct effect of UA on arterial wall elastic properties.
Wave reflections, as estimated by AIx, were shown to inversely correlate with UA levels only in females, whereas no such relationship was substantiated in males. To date, scant data exist regarding the relationship of UA and central hemodynamics. In hyperuricemic stroke survivors, a short course treatment with allopurinol decreased AIx. 26 However, the nature of this relationship has not been explored in other populations. Processes that can cause peripheral vasodilation may reduce the magnitude of the reflected wave and lead to a final decrease of AIx. 27 Systemic inflammatory processes, such as vasculitides, result in decreased AIx values when compared to healthy controls. 28 Taken together, our findings of a negative relationship between UA levels and wave reflections in the presence of a positive association with arterial stiffness only in females are intriguing. However, while arterial stiffness and wave reflec tion indices often change in parallel, this is not always the case. AIx is a composite index that integrates the amount of the wave that is reflected back to the aorta (depending on tone of resistance arteries, which are the main peripheral reflecting sites) and the velocity of the incident and reflected wave (which, in turn, depends on arterial stiffness). 14 Inflammatory processes influence PWV and AIx in a dis parate manner. 21, 27, 29 Peripheral vasodilation as a result of inflammatory stimuli to the arterial wall may be a plausible mechanism. The magnitude of reflected waves decreases and original contributions Uric Acid and Arterial Function in Hypertension leads to a final decrease of AIx despite the opposing effect of increased arterial stiffness. Such dissociation of PWV and AIx has been described in inflammatory states, such as following vaccination and vasculitis. 21, 28 Indeed, UA seems to partake in a proinflammatory pathway. In experimental models, UA upregulated CRP production. 30 Furthermore, UA levels independently correlate with a variety of inflammatory markers and mediators in the general popula tion. 7 Similar associations were confirmed in our population, as UA positively correlated with CRP levels.
Our findings add to the general impression that UA does not have a uniform impact on both sexes. Longitudinal studies in patients with gout have revealed that women are at increased risk for acute myocardial infarction compared to men. 31 Moreover, serum UA levels are independent predictors of worsening coronary endothelial function only in females, and this relationship may be mediated by increased asym metric dimethylarginine levels. 32 Genomewide association studies suggest that UA metabolism is under strong genetic control and that gender discrepancies in gene function exist. 33 The mechanisms that underline UA handling and its gender specific effects deserve further study. Inflammation is an important risk predictor. Accordingly, while lower wave reflec tions imply lower risk, a pronounced inflammatory role for UA in females could be a unifying hypothesis that can account for decreased wave reflections, impaired endothelial function and eventually higher cardiovascular risk.
Given the prognostic role of arterial stiffness for cardio vascular events and its role in the pathogenesis of hyperten sion, our findings may have important clinical implications. Prospective studies have demonstrated independent asso ciations of increased UA levels and cardiovascular events. 2, 3 Furthermore, experimental 34 and clinical 35 data have led to the reappraisal of the role of UA in hypertension. Contrary to the past belief that elevated UA in hypertension was an epi phenomenon, emerging data support an active role for this molecule. [4] [5] [6] Elevated levels of UA predict hypertension inci dence and progression; 4 treatment with allopurinol reduces blood pressure in newly diagnosed hypertensive adolescents 5, 6 and reverses endothelial dysfunction. 36 However, current evidence is insufficient to support or refute the routine use of UAlowering medications in the hypertensive setting. The crosssectional nature of our study does not allow conclusions on causal relationships and additional research is warranted in order to explore the interplay of arterial stiffness, UA, and blood pressure.
A strength of our study is that only newly diagnosed, never treated hypertensives were enrolled, thus avoiding the poten tial confounding factor of antihypertensive medications. UA levels can be modified by the use of antihypertensive medica tion. Diuretics and some βblockers, such as timolol, 37 lead to an increase in serum UA levels, whereas losartan, has a direct uricosuric action in the kidney. 38 Angiotensinconverting enzyme inhibitors and angiotensin receptor blockers reduce the oxidative load and exert an antiinflammatory effect on the blood vessel wall, 39 on top of blood pressure reduction.
Some study limitations should be considered in the interpretation of our results. Owing to the fact that this is a crosssectional, observational study, the results do not infer causality. Our study population consisted solely of white Caucasian subjects, thus the associations observed may not be applicable to other ethnic groups. Inclusion of smok ers, diabetics and dyslipidemics makes our population het erogenous, however, representative of newly diagnosed hypertensives, who often present at the clinic with these commorbidities. This is the first study to explore the associations of UA levels and indices of arterial function in nevertreated hypertensives. In line with experimental data supporting a putative noxious role for UA on the vasculature, we have demonstrated that in nevertreated hypertension a positive association of serum UA levels and large artery stiffness exists, whereas the association with wave reflections is of a negative nature, but weak and only in females. Inflammatory mechanisms may be implicated in these relationships, as positive correlations of UA and inflam matory markers imply. Further research, involving prospective/ intervention studies, is warranted in order to establish whether arterial function mediates the relationship of this molecule and hypertension. In addition, possible gender specific roles of UA remain to be elucidated.
